{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T01:51:31Z","timestamp":1773798691681,"version":"3.50.1"},"reference-count":50,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2012,11,24]],"date-time":"2012-11-24T00:00:00Z","timestamp":1353715200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Birth Defects Research"],"published-print":{"date-parts":[[2013,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>BACKGROUND<\/jats:title><jats:p>Little is known about the etiology of nonsyndromic microtia. This study investigated the hypothesis that microtia is caused by vascular disruption.<\/jats:p><\/jats:sec><jats:sec><jats:title>METHODS<\/jats:title><jats:p>The study analyzed data from the population\u2010based National Birth Defects Prevention Study (NBDPS) for deliveries between 1997 and 2005. Four hundred eleven nonsyndromic cases of microtia, with or without additional defects, were compared to 6560 nonmalformed infants with respect to maternal exposures to vasoactive medications and smoking during the periconceptional period and conditions that have previously been associated with vascular events (multiple gestation, maternal history of type 1, type 2, or gestational diabetes, and hypertension). Odds ratios (ORs) were estimated with multivariable models, controlling for the effects of race\/ethnicity, education, periconceptional folic acid use, and study center.<\/jats:p><\/jats:sec><jats:sec><jats:title>RESULTS<\/jats:title><jats:p>Risk estimates for vasoactive medications and smoking were not meaningfully increased. Maternal type 1\/2 diabetes was diagnosed before or during the index pregnancy in 4% and 1% of cases, respectively, compared to 1% and 0.05% of controls; the adjusted OR for these two groups combined was 7.2 (95% confidence interval [CI], 3.9\u201313.1). Gestational diabetes was observed for 9% of cases and 6% of controls; the OR was moderately elevated (OR, 1.4; 95% CI, 0.9\u20132.0). ORs were also increased for multiple gestations (OR, 2.5; 95% CI, 1.5\u20134.2) and pre\u2010existing hypertension (OR, 1.6; 95% CI, 1.0\u20132.5).<\/jats:p><\/jats:sec><jats:sec><jats:title>CONCLUSIONS<\/jats:title><jats:p>Because ORs were only elevated for diabetes and not for vasoactive exposures or other potential vascular events, findings suggest that some microtia occurrences may be part of the diabetic embryopathy rather than manifestations of vascular disruption. Birth Defects Research (Part A), 2013. \u00a9 2012 Wiley Periodicals, Inc.<\/jats:p><\/jats:sec>","DOI":"10.1002\/bdra.23101","type":"journal-article","created":{"date-parts":[[2012,11,24]],"date-time":"2012-11-24T05:18:03Z","timestamp":1353734283000},"page":"53-59","source":"Crossref","is-referenced-by-count":20,"title":["Vasoactive exposures during pregnancy and risk of microtia"],"prefix":"10.1002","volume":"97","author":[{"given":"Carla M.","family":"Van Bennekom","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allen A.","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia A.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martha M.","family":"Werler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"and the National Birth Defects Prevention Study","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,11,24]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.2008.062158"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.126.3_suppl.627S"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.85.1.1"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/bdra.20626"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8628(19990903)86:1<9::AID-AJMG3>3.0.CO;2-X"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2008.06.028"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.reprotox.2005.01.014"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/tera.1420430106"},{"key":"e_1_2_6_10_1","first-page":"159","article-title":"Late gestational vascular disruptions inducing craniofacial anomalies: a fetal lamb model","volume":"18","author":"Escobar LF","year":"1998","journal-title":"J Craniofac Genet Dev Biol"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/tera.1420410309"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1741-4520.2005.00080.x"},{"key":"e_1_2_6_13_1","first-page":"267","article-title":"Congenital cataract following German measles in the mother, 1941","volume":"19","author":"Gregg N","year":"1991","journal-title":"Aust N Z J Ophthalmol"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(80)90181-3"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.33.10.809"},{"key":"e_1_2_6_16_1","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1542\/peds.67.2.288","article-title":"Vascular etiology of disruptive structural defects in monozygotic twins","volume":"67","author":"Hoyme HE","year":"1981","journal-title":"Pediatrics"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/bdra.20449"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198611273152205"},{"key":"e_1_2_6_19_1","volume-title":"Plastic Surgery","author":"Johnston M","year":"1990"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1177\/10454411950060010301"},{"key":"e_1_2_6_21_1","first-page":"S168","article-title":"The Slone Drug Dictionary: a research driven pharmacoepidemiology tool","volume":"12","author":"Kelley KE","year":"2003","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198510033131401"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1054\/bjps.2002.3902"},{"key":"e_1_2_6_24_1","article-title":"Microtia: epidemiology and genetics","author":"Luquetti DV","year":"2011","journal-title":"Am J Med Genet A"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.33694"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/tera.1420450609"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.32.6.453"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1586\/14760584.8.3.323"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/tera.1420230310"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00146367"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/bdra.10012"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hch107"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1097\/00003081-200003000-00004"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.33636"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1601-6343.2006.00377.x"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1002\/bdra.20042"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0029-7844(02)02242-1"},{"key":"e_1_2_6_38_1","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1001\/jama.1980.03300410037022","article-title":"Hazards of oral anticoagulants during pregnancy","volume":"243","author":"Stevenson RE","year":"1980","journal-title":"JAMA"},{"issue":"103","key":"e_1_2_6_39_1","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1242\/dev.103.Supplement.213","article-title":"Teratogens and craniofacial malformations: relationships to cell death","author":"Sulik KK","year":"1988","journal-title":"Development"},{"key":"e_1_2_6_40_1","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3928\/00904481-19810601-06","article-title":"Fetal vascular disruptions: mechanisms and some resulting birth defects","volume":"10","author":"Van Allen MI","year":"1981","journal-title":"Pediatr Ann"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1002\/1096-8628(20001211)95:4<302::AID-AJMG2>3.0.CO;2-B"},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.2223\/JPED.1441"},{"key":"e_1_2_6_43_1","doi-asserted-by":"publisher","DOI":"10.1067\/mpd.2002.128891"},{"key":"e_1_2_6_44_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9926(199807)58:1<13::AID-TERA5>3.0.CO;2-2"},{"key":"e_1_2_6_45_1","doi-asserted-by":"publisher","DOI":"10.1002\/bdra.20524"},{"key":"e_1_2_6_46_1","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/oxfordjournals.aje.a116145","article-title":"Maternal alcohol use in relation to selected birth defects","volume":"134","author":"Werler MM","year":"1991","journal-title":"Am J Epidemiol"},{"key":"e_1_2_6_47_1","doi-asserted-by":"publisher","DOI":"10.1002\/bdra.20022"},{"key":"e_1_2_6_48_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.EDE.0000059226.36219.DE"},{"key":"e_1_2_6_49_1","unstructured":"WerlerMM SheehanJE MitchellAA.2004b.Diabetes body mass index vitamin supplementation and anotia\/microtia. Available at:http:\/\/www.bu.edu\/slone\/Research\/Studies\/HFM\/Anotia_Microtia_PPT.pdf. Accessed October 27 2012."},{"issue":"116","key":"e_1_2_6_50_1","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/phr\/116.S1.32","article-title":"The National Birth Defects Prevention Study","volume":"1","author":"Yoon PW","year":"2001","journal-title":"Public Health Rep"},{"key":"e_1_2_6_51_1","doi-asserted-by":"publisher","DOI":"10.1002\/bdra.20704"}],"container-title":["Birth Defects Research Part A: Clinical and Molecular Teratology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fbdra.23101","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/bdra.23101","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T17:22:21Z","timestamp":1745342541000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/bdra.23101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,24]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["10.1002\/bdra.23101"],"URL":"https:\/\/doi.org\/10.1002\/bdra.23101","archive":["Portico"],"relation":{},"ISSN":["1542-0752","1542-0760"],"issn-type":[{"value":"1542-0752","type":"print"},{"value":"1542-0760","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,24]]}}}